In vitro Antibacterial Effect Study of Plasma-Activated Saline on Mycobacterium Tuberculosis

DOI: https://doi.org/10.2147/idr.s456181
2024-06-12
Infection and Drug Resistance
Abstract:Jianbao Zheng, 1, 2, &ast Zepeng Dong, 1, &ast Xianzhen Jin, 1 Jing Li, 2 Yuanwu Zou, 2 Guanghong Bai, 2 Qianhong Wu, 2 Shenghang Xu, 3 Zifeng Wang, 3 Xuejun Sun, 1 Dingxin Liu, 3 Li Guo 3 1 Department of General Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China; 2 Tuberculosis Prevention and Treatment Hospital in Shaanxi Province, Xi'an, 710100, People's Republic of China; 3 Center for Plasma Biomedicine, State Key Laboratory of Electrical Insulation and Power Equipment, Xi'an Jiaotong University, Xi'an, 710049, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qianhong Wu; Li Guo, Email ; Purpose: This study aimed to investigate the antibacterial effects of plasma-activated saline (PAS) on My-cobacterium tuberculosis (Mtb). Methods: We conducted a growth assay on 3 strains of Mtb and an antibiotic sensitivity test on 4 strains of Mtb. Both tests included groups treated with normal saline (NS), PAS, and hydrochloric acid (HCl). The test of antibiotic sensitivity consisted of parallel tests with two concentrations of bacteria suspension: 10 − 2 and 10 − 4 . The selected antibiotics were rifampicin (RIF), isoniazid (INH), ethambutol (EMB), and streptomycin (SM). The number of bacteria was determined after one month of culture under different conditions. The Kruskal–Wallis test was used to analyze the differences in grouping factors at representative time points. Results: The growth assay indicated that PAS significantly inhibited the growth of 3 strains of Mtb compared with NS and HCl treatment groups. Furthermore, except for the initial observation time point, the remaining three observation time points consistently demonstrate no significant differences between the NS group and the HCl group. The antibiotic sensitivity test of INH, SM, and RIF indicated that PAS could inhibit the growth of antibiotic-resistant Mtb, and the antibiotic sensitivity test of INH and SM with bacterial suspension concentration of 10 − 2 and SM with bacterial suspension concentration of 10 − 4 showed statistically different results. The antibiotic sensitivity test of EMB indicated that the growth of Mtb in PAS was slower than that in NS and HCl in both antibiotic-resistant and sensitive Mtb, but there was no statistical difference. Conclusion: The study indicates that PAS contains a significant amount of active substances and exhibits high oxidizability and an acidic pH state. The unique physicochemical properties of PAS significantly delayed the growth of Mtb, compared to the NS and the HCl. PAS not only inhibited the growth of drug-sensitive strains but also significantly enhanced the sensitivity of drug-resistant strains to anti-tuberculosis drugs, which may provide a new therapeutic strategy for the treatment of tuberculosis. Keywords: plasma-activated saline, mycobacterium tuberculosis, antibacterial effect, antibiotic sensitivity Tuberculosis (TB) remains a significant global health concern, despite recent advancements in its management. 1 Standard TB treatment respond in only 80% of patients, well below the World Health Organisation's target of 90%. 2 Multidrug-resistant TB (MDR-TB) worsens when Mtb develops resistance to anti-TB drugs. 3 As a result, cure rates for MDR-TB and extensively drug-resistant tuberculosis have fallen by 50% and 30%. 4 MDR-TB strains, which resist conventional anti-TB drugs, pose a challenge due to prolonged treatment periods and severe side effects, compounded by patient non-compliance leading to further drug resistance. 5 Tracheobronchial tuberculosis, affecting a quarter of patients, presents additional complexities. Unlike pulmonary TB, it often requires extended treatment, sometimes necessitating local administration due to fibroplasia and caseous necrosis impeding drug penetration. 6 Even with appropriate medication, tracheobronchial TB can cause irreversible narrowing, often requiring surgical intervention, imposing substantial physical and financial burdens on patients. 7 In this context, exploring alternative treatment modalities is crucial. Plasma, with its potent bactericidal properties driven by reactive oxygen species (ROS), emerges as a promising avenue. 8,9 At present, there are few studies on the inactivation effect of plasma on TB, and most of them focus on the gaseous state of plasma. 10,11 Lee C 12 proved that OH radicals in a Nonthermal Plasma Jet (NTPJ) were -Abstract Truncated-
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?